ADPT — Adaptive Biotechnologies Corp
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1478320 ·
Last close
$28.49
Market Cap
$4.61B
52W High
$32.21
52W Low
$12.00
ADV30
2,184,826
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 83,902,000 | 63,969,000 | -457,000 | 2,876,000 | 683,120,000 | 75,615,000 | 499,229,000 |
| Jun 2026 | 71,553,000 | 51,388,000 | -15,770,000 | -39,788,000 | 640,678,000 | 169,873,000 | 490,016,000 |
| Mar 2026 | 70,874,000 | 52,166,000 | -19,206,000 | -20,033,000 | 505,943,000 | 77,581,000 | 281,702,000 |
| Dec 2025 | 71,681,000 | 53,457,000 | -12,773,000 | -13,579,000 | 512,736,000 | 70,495,000 | 287,735,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-4,277,000
Investing CF
$-167,646,000
Financing CF
$192,520,000
CapEx
$-4,545,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.45
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,420,268,000
Inventory
$10,055,000
Receivables
$66,671,000
ST Investments
$223,339,000
EBIT TTM
$-61,689,000
Pretax Income TTM
$-70,729,000
Interest Exp TTM
$9,040,000
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$298,009,984
EBITDA
$-32,873,000
Free Cash Flow
$14,434,250
Enterprise Value
$4,647,004,672
Total Cash
$298,953,984
Total Debt
$408,971,008
Shares Out
161,876,694
Trailing EPS
$-0.45
Book Value
$1.09
ROE
-36.4%
ROA
-5.1%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 276,976,000 | -57,123,000 | -59,499,000 | 512,736,000 | 287,735,000 | 218,793,000 | -45,986,000 |
| Dec 2024 | 178,957,000 | -155,344,000 | -159,492,000 | 539,376,000 | 336,891,000 | 202,709,000 | -95,212,000 |
| Dec 2023 | 170,276,000 | -201,606,000 | -225,250,000 | 661,134,000 | 352,856,000 | 308,399,000 | -156,324,000 |
| Dec 2022 | 185,308,000 | -200,186,000 | -200,191,000 | 856,617,000 | 392,519,000 | 464,165,000 | -183,945,000 |
TTM Snapshot
Revenues TTM
$308,081,000
NetIncome TTM
$-63,854,000
OpCashFlow TTM
—
Assets (Latest)
$640,678,000
Forward EPS
$-0.18
Max Pain — expiry 2027-01-15
max pain strike: $15.00 · spot: $28.46 · call oi: 2,528 · put oi: 150
Expected Move to 2027-01-15:
±$7.00
(24.60%) —
implied range
$21.46 –
$35.46
· ATM straddle on $30.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRSP | CRISPR Therapeutics AG | $3.89B | $40.15 | — |
| SRRK | Scholar Rock Holding Corp | $5.50B | $45.08 | — |
| TARS | Tarsus Pharmaceuticals, Inc. | $3.86B | $78.20 | — |
| RLAY | Relay Therapeutics, Inc. | $3.64B | $16.47 | — |
| IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $3.48B | $7.53 | — |
News headlines (Yahoo Finance, 1h cache)
Adaptive Biotechnologies Highlights clonoSEQ’s Central Role in Advancing MRD-Guided Care Across Hematology at ASH 2026
2026-11-18 08:00 · Yahoo
DNA Sequencing - Global Strategic Business Report: Secure Share of a US$17.1 Billion Market by 2030 as Eppendorf, Adaptive Biotechnologies, BGI Genomics, and Annoroad Reshape Competition
2026-11-11 14:23 · Yahoo
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
2026-11-10 21:05 · Yahoo
Adaptive Biotechnologies Corporation (ADPT) Hits Fresh High: Is There Still Room to Run?
2026-11-10 13:15 · Yahoo
Adaptive Biotechnologies (ADPT) Reported Mixed Q3 Results, Is The Stock Fully Valued?
2026-11-08 00:19 · Yahoo
Adaptive (ADPT) Q3 2026 Earnings Call Transcript
2026-11-05 15:13 · Yahoo
Adaptive Biotechnologies Corp (ADPT) Q3 2026 Earnings Call Highlights: First Profitable Quarter ...
2026-11-05 07:14 · Yahoo
Adaptive Biotechnologies Q3 Earnings Call Highlights
2026-11-05 00:14 · Yahoo
Adaptive Biotechnologies (ADPT) Q3 Earnings and Revenues Top Estimates
2026-11-04 23:45 · Yahoo
Ionis' Tryngolza Gets EU Approval for Severe Hypertriglyceridemia
2026-11-18 16:34 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.